Patent · US Active

Polymorph of a pharmaceutical

US9255092B2 · kind B2 · utility

0Cited by
14References
4Claims
0Family size

Assignee

Inventors

Key dates

Filing dateOct 14, 2013
Grant dateFeb 9, 2016
Priority date—
Expiry dateOct 14, 2033

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D277/28
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

A new crystalline polymorph of ritonavir and methods for its use and preparation are disclosed.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.